Cosmos Holdings Inc (COSM)
NASDAQ:COSM
Want to see COSM full AI Analyst Report?
COSM Stock Chart & Stats
$0.52
-$0.04(-5.45%)
At close: 4:00 PM EST
$0.52
-$0.04(-5.45%)
Day’s Range― - ―
52-Week Range$0.28 - $1.32
Previous CloseN/A
Volume59.12K
Average Volume (3M)1.18M
Market Cap
$18.14M
Enterprise Value$20.83M
Total Cash (Recent Filing)$761.83K
Total Debt (Recent Filing)$10.79M
Price to Earnings (P/E)―
Beta2.07
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.63
Shares Outstanding50,824,657
10 Day Avg. Volume1,246,475
30 Day Avg. Volume1,183,471
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.82
Price to Sales (P/S)0.23
P/FCF Ratio-1.77
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit2.64
Enterprise Value/Ebitda-1.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$98.60M
Bulls Say, Bears Say
Bulls Say
Revenue Recovery & Margin ImprovementRevenue rebound to ~$65.3M (2025 vs ~$50.3M in 2022) and a rising gross margin (about 12.1% in 2025) reflect improving core sales mix and pricing leverage. These are durable fundamentals that, if sustained, support a credible path toward narrowing losses and future operating leverage.
Manageable Leverage ProfileReported debt around $10.8M and a moderate debt-to-equity (~0.59) indicate the company is not over-levered today, giving financial flexibility for commercialization or targeted investment. This balance-sheet posture reduces near-term solvency risk compared with prior highly levered periods.
New U.S. Commercial Initiatives (Cur18b, Liv18)Planned U.S. launches (Cur18b and Liv18) represent a structural business expansion into a larger market and a direct commercialization strategy. Expected incremental revenue provides a durable new revenue stream potential and diversifies geographic mix over the medium term.
Bears Say
Persistent Negative Operating Cash FlowChronic negative operating cash flow (about -$8.4M in 2025) and recurring negative free cash flow signal ongoing cash burn. Over months to years this forces dependence on external financing or asset sales, constraining strategic options and increasing dilution or borrowing risk.
Structural Unprofitability And Large LossesSizable operating and net losses (EBIT roughly -$16.7M; net margin ~-29%) reflect an earnings profile that remains structurally unprofitable. Persistent losses erode retained capital, limit reinvestment capacity, and make achieving sustainable margins a multi-quarter strategic challenge.
Material Equity Erosion Since 2022Equity reduction from about $39.7M (2022) to $18.4M (2025) documents capital erosion from losses. A thinner equity base reduces the cushion against downturns, raises refinancing needs, and increases the likelihood of dilutive capital raises or higher-cost debt if cash flow fails to turn positive.
Cosmos Holdings News
COSM FAQ
What was Cosmos Holdings Inc’s price range in the past 12 months?
Cosmos Holdings Inc lowest stock price was $0.28 and its highest was $1.32 in the past 12 months.
What is Cosmos Holdings Inc’s market cap?
Cosmos Holdings Inc’s market cap is $18.14M.
When is Cosmos Holdings Inc’s upcoming earnings report date?
Cosmos Holdings Inc’s upcoming earnings report date is May 20, 2026 which is in 14 days.
How were Cosmos Holdings Inc’s earnings last quarter?
Cosmos Holdings Inc released its earnings results on Apr 15, 2026. The company reported -$0.04 earnings per share for the quarter, missing the consensus estimate of -$0.01 by -$0.03.
Is Cosmos Holdings Inc overvalued?
According to Wall Street analysts Cosmos Holdings Inc’s price is currently Overvalued.
Does Cosmos Holdings Inc pay dividends?
Cosmos Holdings Inc does not currently pay dividends.
What is Cosmos Holdings Inc’s EPS estimate?
Cosmos Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cosmos Holdings Inc have?
Cosmos Holdings Inc has 50,824,657 shares outstanding.
What happened to Cosmos Holdings Inc’s price movement after its last earnings report?
Cosmos Holdings Inc reported an EPS of -$0.04 in its last earnings report, missing expectations of -$0.01. Following the earnings report the stock price went up 16.766%.
Which hedge fund is a major shareholder of Cosmos Holdings Inc?
Currently, no hedge funds are holding shares in COSM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cosmos Holdings Inc
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Technical Analysis
Ownership Overview
17.44% Insiders
0.60% Mutual Funds
0.07% Other Institutional Investors
81.62% Public Companies and
Individual Investors